title: Reply to the letter to the editor of francisco José Fernández-Fernández et al.
authors.affiliation: Department of Rheumatology, Clinical Immunology and Allergology, University Hospital, University of Bern, Switzerland. MichaelN.Seitz@insel.ch
authors.forename: Mn
authors.initials: M
authors.lastname: Seitz
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D012074:Remission Induction / Q000379:methods*; D000093242:Interleukin-6 Inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D000093242:Interleukin-6 Inhibitors